DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (887)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 887   Next >>

Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-15
    End date: 2012-07-13

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Other drugs received by patient: Diflunisal; Januvia; Basen



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Pancreatitis Acute, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-15

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Telaprevir
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Germany on 2012-08-27

Patient:

Reactions: Maternal Exposure Before Pregnancy, Abortion Induced

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis
    End date: 2012-01-01

Rebetol
    Dosage: unk
    End date: 2012-01-01

Victrelis
    Dosage: 200 mg, qd
    Indication: Hepatitis
    Start date: 2012-01-09
    End date: 2012-05-01

Other drugs received by patient: Lexotanil



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Generalised Erythema

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-14

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-05-15

Rebetol
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-05

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-06-11

Other drugs received by patient: Norvasc; Rinderon V; Allopurinol; Hirudoid; Xyzal; Allopurinol; Prednisolone; Rabeprazole Sodium; Rabeprazole Sodium; [composition Unspecified]; Clobetasol Propionate; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Exposure VIA Father

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram, qw
    Start date: 2012-05-02
    End date: 2012-05-02

PEG-Intron
    Dosage: 40 microgram, qw
    Start date: 2012-06-06
    End date: 2012-06-20

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-04-18
    End date: 2012-04-18

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-04-11

PEG-Intron
    Dosage: 30 microgram,
    Start date: 2012-06-27
    End date: 2012-06-27

PEG-Intron
    Dosage: 75 microgram, qw
    Start date: 2012-04-25
    End date: 2012-04-25

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-05-09
    End date: 2012-05-30

PEG-Intron
    Dosage: 40 microgram, unk
    Start date: 2012-07-04

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11

Telavic
    Dosage: 1.5 g, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-04-14

Telavic
    Dosage: 1.5 g, qd
    Administration route: Oral
    End date: 2012-06-27

Telavic
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-17

Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-04

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-08

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-02-07

Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8 microgram per kilogram, qw
    Start date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-24

PEG-Intron
    Dosage: 1.0 microgram per kilogram, qw
    Start date: 2012-05-01
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-07-12

Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-07

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-30

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-06-24

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-08

Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Psychiatric Symptom

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-13

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-16

Telavic
    Dosage: cumulative dose: 56250 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Other drugs received by patient: Loxoprofen; Allopurinol



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Renal Impairment, Anaemia, Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-24

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-25

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-17

Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-25

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-02

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-07-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-25

Patient:

Reactions: Fatigue, RED Blood Cell Count Decreased, NO Therapeutic Response, Insomnia, Dysuria, Constipation

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-25

Patient:

Reactions: Blood Creatinine Increased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.43 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-17

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-15

Telavic
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-07-16
    End date: 2012-07-17

Other drugs received by patient: Candesartan Cilexetil; Ursodiol; Januvia; Miglitol; Glimepiride; Glimepiride; Zetia



Possible PEG-Intron side effects in

Reported by a pharmacist from Japan on 2012-08-25

Patient:

Reactions: Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.75 microgram per kilogram, unk
    Start date: 2012-07-16

PEG-Intron
    Dosage: 1.5mcg/kg
    Start date: 2012-07-09

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-07-09

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Start date: 2012-07-09

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-13



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Hepatic Function Abnormal, Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-30

Incivek
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-30

PEG-Intron
    Dosage: 1.2mcg/kg/week
    Start date: 2012-03-23

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-03-22

PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    End date: 2012-05-04

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-20

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-05-11

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-13
    End date: 2012-04-19

Other drugs received by patient: Branute; Allegra; Selbex; Loxoprofen; Posterisan; Posterisan; Heparinoid; Flurbiprofen; Branute; Hirudoid; Livostin; Flurbiprofen; Livostin; Allegra



Possible PEG-Intron side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 54 year old female

Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-28

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-06-12

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-13
    End date: 2012-06-19

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-20
    End date: 2012-07-31

VX-950
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-05-08

Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Haemoglobin Decreased, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-11

Rebetol
    Dosage: unk

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-16

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-06-24

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-16
    End date: 2012-07-02

Telavic
    Dosage: 1000 unk, unk
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-09

Other drugs received by patient: Valsartan and Hydrochlorothiazide



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-19
    End date: 2012-07-30



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-06-02

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2008-02-29
    End date: 2008-03-06

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2008-03-07



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Stevens-Johnson Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-05-14

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-05-14

PEG-Intron
    Dosage: dosage is uncertain during a day.
    Start date: 2012-05-24

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-29

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-30

Rebetol
    Dosage: dosage is uncertain during a day.
    Administration route: Oral
    Start date: 2012-05-24

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-14

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-05-14

Other drugs received by patient: Diovan; Nizatidine; Nizatidine; Loxonin; Diovan; Primperan TAB; Diclofenac Sodium; Allopurinol; Urso 250; Norvasc; Urso 250; Norvasc



Possible PEG-Intron side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-24

Patient: female

Reactions: Back Pain, Oedema Peripheral, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: dosage form: unspecified
    Indication: Hepatitis C
    Start date: 2012-05-01

Ribavirin
    Dosage: dosage form: unspecified
    Indication: Hepatitis C
    Start date: 2012-05-01

VX-950
    Dosage: 750 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-01
    End date: 2012-07-22



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Impairment, Blood Creatinine Increased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-28
    End date: 2012-06-04

Rebetol
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-28
    End date: 2012-06-01

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient: Urso 250



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Disorder, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-28

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-10

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-31

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-06-01

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-03

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-21

Telavic
    Dosage: 1500 mg, qd
    Start date: 2012-06-22
    End date: 2012-07-20

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-31

Other drugs received by patient: Ferotym; Livalo; Epadel S; Claritin Reditabs



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-20

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-19

Telavic
    Dosage: 1500 milligrams, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06

Other drugs received by patient: Lexotan; Norvasc; Mucosta; Epadel S; Ferotym; Depas; Maglax (Magnesium Oxide); Claritin Reditabs Tablets 10 MG; Livalo



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014